Deaths and Years of Potential Life Lost From Excessive Alcohol Use - United States, 2011-2015.
Journal
MMWR. Morbidity and mortality weekly report
ISSN: 1545-861X
Titre abrégé: MMWR Morb Mortal Wkly Rep
Pays: United States
ID NLM: 7802429
Informations de publication
Date de publication:
31 Jul 2020
31 Jul 2020
Historique:
entrez:
31
7
2020
pubmed:
31
7
2020
medline:
1
8
2020
Statut:
epublish
Résumé
Excessive alcohol use is a leading cause of preventable death in the United States (1) and costs associated with it, such as those from losses in workplace productivity, health care expenditures, and criminal justice, were $249 billion in 2010 (2). CDC used the Alcohol-Related Disease Impact (ARDI) application* to estimate national and state average annual alcohol-attributable deaths and years of potential life lost (YPLL) during 2011-2015, including deaths from one's own excessive drinking (e.g., liver disease) and from others' drinking (e.g., passengers killed in alcohol-related motor vehicle crashes). This study found an average of 93,296 alcohol-attributable deaths (255 deaths per day) and 2.7 million YPLL (29 years of life lost per death, on average) in the United States each year. Of all alcohol-attributable deaths, 51,078 (54.7%) were caused by chronic conditions, and 52,361 (56.0%) involved adults aged 35-64 years. Age-adjusted alcohol-attributable deaths per 100,000 population ranged from 20.3 in New Jersey and New York to 52.3 in New Mexico. YPLL per 100,000 population ranged from 613.8 in New York to 1,651.7 in New Mexico. Implementation of effective strategies for preventing excessive drinking, including those recommended by the Community Preventive Services Task Force (e.g., increasing alcohol taxes and regulating the number and concentration of alcohol outlets), could reduce alcohol-attributable deaths and YPLL.
Identifiants
pubmed: 32730240
doi: 10.15585/mmwr.mm6930a1
pmc: PMC7392395
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
981-987Commentaires et corrections
Type : RepublishedIn
Type : ErratumIn
Déclaration de conflit d'intérêts
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Timothy Stockwell reports grants and personal fees from Alko, Finland, outside the submitted work. Richard Saitz reports nonfinancial support from Alkermes; personal fees from UpToDate and Massachusetts Medical Society; support and consulting fees from the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, and the Patient-Centered Outcomes Research Institute; travel support and consulting fees from the American Medical Association, the American Society of Addiction Medicine, Wolters Kluwer, National Council on Behavioral Healthcare, the International Network on Brief Intervention for Alcohol and other drugs, Systembolaget, Kaiser Permanente, RAND, the Institute for Research and Training in the Addictions, the National Council on Behavioral Healthcare, Charles University (Czech Republic), National Committee on Quality Assurance, and the University of Oregon; and salary support from Burroughs Wellcome Fund. No other potential conflicts of interest were disclosed.
Références
Am J Prev Med. 2019 Aug;57(2):197-208
pubmed: 31200998
Am J Public Health. 2015 Apr;105(4):816-22
pubmed: 25122017
Prev Chronic Dis. 2014 Jun 26;11:E109
pubmed: 24967831
JAMA. 2018 Apr 10;319(14):1444-1472
pubmed: 29634829
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49
pubmed: 26987082
Addiction. 2010 Sep;105(9):1589-96
pubmed: 20626370
Ann Emerg Med. 1999 Jun;33(6):659-68
pubmed: 10339681
Addiction. 2006 Dec;101(12):1711-8
pubmed: 17156170
Am J Prev Med. 2015 Nov;49(5):e73-e79
pubmed: 26477807